Beta Blockers or Calcium Channel Blockers as Primary Antianginal Drug after Percutaneous Coronary Intervention: Prescription Pattern and its association with Clinical Outcome
![]() |
Noh, Sun Young
(Department of Pharmacy, Seoul National University Hospital)
Jo, Yun Hee (Department of Pharmacy, Seoul National University Hospital) Cho, Yoon Sook (Department of Pharmacy, Seoul National University Hospital) Hahn, Hyeon Joo (Department of Pharmacy, Seoul National University Hospital) Lee, Hae-Young (Department of Internal Medicine, Seoul National University Hospital) Lee, Ju-Yeun (College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University) |
1 | Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:e44-e164. DOI |
2 | Abrams J. Chronic stable angina. N Engl J Med 2005;352:2524-33. DOI |
3 | Kohro T, Hayashi D, Okada Y, et al. Effects of medication on cardiovascular events in the Japanese coronary artery disease (JCAD) study. Circ J 2007;71:1835-40. DOI |
4 | Borden WB, Redberg RF, Mushlin AI, et al. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. JAMA 2011;305:1882-89. DOI |
5 | Endo A, Kohsaka S, Miyata H, et al. Disparity in the application of guideline-based medical therapy after percutaneous coronary intervention:analysis from the Japanese prospective multicenter registry. Am J Cardiovasc Drugs 2013;13:103-12. DOI |
6 | Jiang J, Wang X, Jia J, et al. Current status and influence factors of beta blocker prescription in Chinese patients with stable angina pectoris. Zhonghua Xin Xue Guan Bing Za Zhi 2015;43:227-33. |
7 |
Freemantle N, Cleland J, Young P, et al. |
8 | Shu de F, Dong BR, Lin XF, et al. Long-term beta blockers for stable angina: systematic review and meta-analysis. Eur J Prev Cardiol 2012;19:330-41. DOI |
9 | Garg P, Wijeysundera HC, Yun L, et al. Practice patterns and trends in the use of medical therapy in patients undergoing percutaneous coronary intervention in Ontario. J Am Heart Assoc 2014;3(4):e000882. DOI |
10 | James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20. DOI |
11 | Heidenreich PA, McDonald KM, Hastie T, et al. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. JAMA 1999;281:1927-36. DOI |
12 | Rehnqvist N, Hjemdahl P, Billing E, et al. Effects of metoprolol vs verapamil in patients with stable angina pectoris. Eur Heart J 1996;17:76-81. DOI |
13 | Fox KM, Mulcahy D, Findlay I, et al. Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group. Eur Heart J 1996;17:96-103. DOI |
14 | Von Arnim T. Medical treatment to reduce total ischemic burden: total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. The TIBBS Investigators. J Am Coll Cardiol 1995;25:231-8. DOI |
15 | Dwivedi SK, Saran RK, Mittal S, et al. Silent ischemic interval on exercise test is a predictor of response to drug therapy: a randomized crossover trial of metoprolol versus diltiazem in stable angina. Clin Cardiol 2001;24:45-9. DOI |
![]() |